69 Results for "

CA-II

" in MedChemExpress (MCE) Product Catalog:
Products (69)

69 Results for "CA-II" in MCE Product Catalog:

Cat. No.: HY-12596
CAS No.: 871824-55-4
JNJ-26489112, a CNS-active agent, exhibits broad-spectrum anticonvulsant activity in rodents against audiogenic, electrically-induced, and chemically-induced seizures. JNJ-26489112 inhibits voltage-gated Na + channels and N-type Ca 2+ channels, and is effective as a K + channel opener. JNJ-26489112 has very weak inhibition of CA-II (IC50=35 μM) and CA-I (18 μM) .
loading...
    loading...
Cat. No.: HY-151916
CAS No.: 2883495-35-8
Purity:  99.57%
Enpp/Carbonic anhydrase-IN-1 (compound 1e) is a potent Enpp and carbonic anhydrase inhibitor with IC50s of 1.36, 1.35, 3.00, 0.88, 1.02 μM for NPP1, NPP2, NPP3, CA-II, CA-IX respectively. Enpp/Carbonic anhydrase-IN-1 shows antiproliferative activity for cancer cells and low cytotoxic against normal cells. Enpp/Carbonic anhydrase-IN-1 induces Apoptosis .
loading...
    loading...
Cat. No.: HY-32933
CAS No.: 149104-90-5
Target:  

Carbonic Anhydrase

Research Areas:  

Metabolic Disease

4-Acetylphenylboronic acid is a potent inhibitor of carbonic anhydrases II(CA II), with IC50s of 246 μM and 281.40 μM for bovine CA II (bCA II) and human CA II (hCA II). 4-Acetylphenylboronic acid can be obtained via mechanochemistry and solvent evaporation. 4-Acetylphenylboronic acid has a loss of the carbonyl group at 500-550 K .
loading...
    loading...
Cat. No.: HY-129781
CAS No.: 96803-89-3
Target:  

Carbonic Anhydrase

Research Areas:  

Endocrinology

L-650719 is a topical carbonic anhydrase inhibitor (CAI) with a Ki of 10 nM for CA II. L-650719 has shown good intraocular pressure-lowering effects in a rabbit model. L-650719 may be used in glaucoma research .
loading...
    loading...
Cat. No.: HY-175239
Target:  

Carbonic Anhydrase

Research Areas:  

Neurological Disease

CAII/CAXII-IN-1 (compound 8d) is a CAII/CAXII inhibitor with IC50 values of 0.38 µM and 0.61 µM for CAII and CAXII, respectively .
loading...
    loading...
Cat. No.: HY-B0109S
CAS No.: 1227097-70-2
Dorzolamide-d5 is the deuterium labeled Dorzolamide. Dorzolamide (L671152) is a potent carbonic anhydrase II inhibitor, with IC50 values of 0.18 nM and 600 nM for red blood cell CA-II and CA-I respectively. Dorzolamide possesses anti-tumor activity .
loading...
    loading...
Cat. No.: HY-B0109AR
CAS No.: 130693-82-2
Synonyms: L671152 hydrochloride(Standard); MK507 hydrochloride (Standard)
Research Areas:  

Others

Dorzolamide (hydrochloride) (Standard) is the analytical standard of Dorzolamide (hydrochloride). This product is intended for research and analytical applications. Dorzolamide (L671152) hydrochloride is a potent carbonic anhydrase II inhibitor, with IC50 values of 0.18 nM and 600 nM for red blood cell CA-II and CA-I respectively. Dorzolamide possesses anti-tumor activity .
loading...
    loading...
Cat. No.: HY-B0109AS
Synonyms: L671152-d3 hydrochloride; MK507-d3 hydrochloride
Dorzolamide-d3 hydrochloride is deuterated labeled Dorzolamide hydrochloride (HY-B0109A). Dorzolamide (L671152) hydrochloride is a potent carbonic anhydrase II inhibitor, with IC50 values of 0.18 nM and 600 nM for red blood cell CA-II and CA-I respectively. Dorzolamide possesses anti-tumor activity .
loading...
    loading...
Cat. No.: HY-B0109AS1
CAS No.: 2749856-75-3
Synonyms: L671152 hydrochloride-d5; MK507 hydrochlorid-d5
Dorzolamide-d5(hydrochloride) (L671152 hydrochloride-d5) is deuterium labeled Dorzolamide (hydrochloride). Dorzolamide (L671152) hydrochloride is a potent carbonic anhydrase II inhibitor, with IC50 values of 0.18 nM and 600 nM for red blood cell CA-II and CA-I respectively. Dorzolamide possesses anti-tumor activity .
loading...
    loading...
Cat. No.: HY-B0588AS
Synonyms: AL-4862-d5 hydrochloride
Brinzolamide-d5 (hydrochloride) is the deuterium labeled Brinzolamide hydrochloride . Brinzolamide (AL-4862) hydrochloride is a selective carbonic anhydrase II inhibitor with an IC50 value of 3.2 nM. Brinzolamide hydrochloride reduces intraocular pressure (IOP) by inhibiting ciliary CA-II and decreasing atrial fluid secretion. Brinzolamide hydrochloride can be used in glaucoma disease research .
loading...
    loading...
Cat. No.: HY-157139
CAS No.: 2091887-74-8
Purity:  99.90%
Research Areas:  

Inflammation/Immunology

ALP/Carbonic anhydrase-IN-1 (Compound 1e) is a dual carbonic anhydrase (CA) and alkaline phosphatase (ALP) inhibitor. ALP/Carbonic anhydrase-IN-1 shows IC50 values of 0.44 µM, 1.61 µM, 0.51 µM, and 0.107 µM for CA-II, CA-IX, CA-XII, and ALP, respectively .
loading...
    loading...
Cat. No.: HY-B0588R
CAS No.: 138890-62-7
Synonyms: AL-4862 (Standard)
Brinzolamide (Standard) is the analytical standard of Brinzolamide. This product is intended for research and analytical applications. Brinzolamide (AL-4862) is a selective carbonic anhydrase II inhibitor with anIC50 value of 3.2 nM. Brinzolamide hydrochloride reduces intraocular pressure (IOP) by inhibiting ciliary CA-II and decreasing atrial fluid secretion. Brinzolamide can be used in glaucoma disease research .
loading...
    loading...
Cat. No.: HY-184559
CAS No.: 2673323-38-9
Target:  

Carbonic Anhydrase

Research Areas:  

Neurological Disease

CAII-IN-16 is a selective inhibitor of carbonic anhydrase II (CA II), with an IC50 of 0.5 nM against hCA II. CAII-IN-16 exhibits excellent intraocular pressure-lowering activity in a rabbit glaucoma animal model. CAII-IN-16 can be used for the research of glaucoma .
loading...
    loading...
Cat. No.: HY-183283
CAII-IN-15 is a potent carbonic anhydrase II (CA II) inhibitor with a hCA II IC50 of 10 nM. CAII-IN-15 elevates cGMP levels, releases nitric oxide, reduces oxidative stress, and exhibits neuroprotective activity in vitro. CAII-IN-15 inhibits NLRP3 inflammasome activation, reduces neuronal apoptosis. CAII-IN-15 reduces Intraocular pressure (IOP) in rabbits. CAII-IN-15 can be used for the research of glaucoma .
loading...
    loading...
Cat. No.: HY-RS01768
Research Areas:  

Others

CA2 Human Pre-designed siRNA Set A contains three designed siRNAs for CA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-180056
Research Areas:  

Neurological Disease

CAII-IN-12 (compound 6c) is a potent and selective carbonic anhydrase (CA) II and VII inhibitor (hCA II Ki = 47.8 nM, hCA VII Ki = 3.6 nM) with anti-epilepitic activity. CAII-IN-12 displays selectivity over hCA I (Ki = 370 nM). CAII-IN-12 exhibits potent anticonvulsant activity in both Pentylenetetrazol- and Pilocarpine (HY-B0726A)-induced seizure mouse models. CAII-IN-12 increases expression of KCC2 in the hippocampus, maintains neuronal integrity, and reduces mTOR activity. CAII-IN-12 can be used for epilepsy research .
loading...
    loading...
Cat. No.: HY-115999
CAS No.: 2883451-38-3
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

Carbonic anhydrase inhibitor 12 is a potent CA II inhibitor, also has inhibitory activity in CA I (Kis of 1.72 and 271 nM in CA II and CA I, respectively). Carbonic anhydrase inhibitor 12 has potent anticancer activity against different cancer cell lines .
loading...
    loading...
Cat. No.: HY-W424792A
CAS No.: 2967475-56-3
Research Areas:  

Neurological Disease

O-Desmethyl Brinzolamide hydrochloride (compound 6a), an active metabolite of Brinzolamide, is a carbonic anhydrase (CA) inhibitor with a Kd of 0.136 nM for CA II and an IC50 of 165 nM for CA IV .
loading...
    loading...
Cat. No.: HY-RS01909
Research Areas:  

Others

Car2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Car2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-115998
CAS No.: 2411059-71-5
Target:  

Carbonic Anhydrase

Research Areas:  

Cancer

Carbonic anhydrase inhibitor 11 (compound VI) is a potent, selective carbonic anhydrase inhibitor. Carbonic anhydrase inhibitor 11 shows Ki values of 40, 39, 200 and 900 nM against CA II, IX, and XII, respectively .
loading...
    loading...